Study by Professor Idit Maya and her team has "significant implications, especially for Jews in Israel and the Diaspora."The ...

Overall, the data from all of the patient groups revealed 11 F722fs carriers out of 743 Ashkenazi Jewish men with prostate cancer — or 1.5% — and 21 with the mutation out of 6,809 Ashkenazi ...

Overall, the data from all of the patient groups revealed 11 F722fs carriers out of 743 Ashkenazi Jewish men with prostate cancer - or 1.5% - and 21 with the mutation out of 6,809 Ashkenazi Jewish ...

Bonnie says, “Tay-Sachs is commonly carried by Ashkenazi Jews, which we both are. Our obstetrician should have met the standard of care and provided us with the option to obtain genetic testing.

BRCA genetic mutations, which are 10 times more common among Ashkenazi Jews than among the general U.S. population, significantly increase the risks of developing breast cancer and ovarian cancer.

While one in 29 Ashkenazi Jews - those of Eastern Europe descent - are carriers for Tay-Sachs, one in four are carriers of at least one of the 19 disorders being screened for Sunday.

But Gaucher disease type 1 is much more common in the Ashkenazi Jewish population, affecting about 1 in 450 live births. Experts estimate that about 1 in 18 people in the Ashkenazi Jewish ...

This enzyme deficiency is caused by an inborn genetic defect that has been traced back 500 years to Ashkenazic Jews who lived in Lithuania and Poland. Because Jews usually marry within their own ...

Rather than using a rigid, one-size-fits-all global cutoff, the new model allows for a personalized “true risk threshold.” ...

On Oct. 1, 2023, a hacker known as “Golem” claimed to have stolen DNA data from 23andMe and according, to the complaint, “As proof…published the alleged data of one million users of Jewish ...

Researchers used whole-genome sequencing from diverse populations to identify 156 variants, including 133 novel ones, linked ...